Abstract:Enhancing differentiation of mesenchymal stem cells (MSCs) to endothelial cells may improve their ability to vascularize tissue and promote wound healing. This study describes a novel role for nitric oxide (NO) in reprogramming MSCs towards an endothelial lineage and highlights the role of Wnt signaling and epigenetic modification by NO. Rat MSCs were transduced with lentiviral vectors expressing endothelial nitric oxide synthase (pLV‐eNOS) and a mutated caveolin gene (pLV‐CAV‐1F92A) to enhance NO generation resulting in increased in vitro capillary tubule formation and endothelial marker gene expression. An exogenous source of NO could also stimulate CD31 expression in MSCs. NO was associated with an arterial‐specific endothelial gene expression profile of Notch1, Dll4, and Hey2 and significantly reduced expression of venous markers. Wnt signaling associated with NO was evident through increased gene expression of Wnt3a and β‐catenin protein, and expression of the endothelial marker Pecam‐1 could be significantly reduced by treatment with the Wnt signaling inhibitor Dkk‐1. The role of NO as an epigenetic modifier was evident with reduced gene expression of the methyltransferase, DNMT1, and bisulfite sequencing of the endothelial Flt1 promoter region in NO‐producing MSCs showed significant demethylation compared to control cells. Finally, subcutaneous implantation of NO‐producing MSCs seeded in a biomaterial scaffold (NovoSorb®) resulted in survival of transplanted cells and the formation of blood vessels. In summary, this study describes, NO as a potent endothelial programming factor which acts as an epigenetic modifier in MSCs and may provide a novel platform for vascular regenerative therapy.

Pharmacological Activation of Nitric Oxide Signaling Promotes Human Hematopoietic Stem Cell Homing and Engraftment

Nitric Oxide Inhibits Hetero-adhesion of Cancer Cells to Endothelial Cells: Restraining Circulating Tumor Cells from Initiating Metastatic Cascade

Nitric oxide induces promyelocytic cell growth arrest and apoptosis through deactivation of Akt pathway.

Nitric Oxide: News from Stem Cells to Platelets

Progress Towards Improving Homing and Engraftment of Hematopoietic Stem Cells for Clinical Transplantation

Molecular Regulators of Chemotaxis in Human Hematopoietic Stem Cells

Enhancing Human Cord Blood Hematopoietic Stem Cell Engraftment by Targeting Nuclear Hormone Receptors

Enhancing human cord blood hematopoietic stem cell engraftment by targeting nuclear hormone receptors.

Generation of a nitric oxide signaling pathway in mesenchymal stem cells promotes endothelial lineage commitment

Protein S-nitrosylation regulates proteostasis and viability of hematopoietic stem cell during regeneration

Nitric oxide promotes epidermal stem cell migration via cGMP-Rho GTPase signalling

Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy

Neutralizing Negative Epigenetic Regulation by HDAC5 Enhances Human Haematopoietic Stem Cell Homing and Engraftment

Heme Oxygenase 1 (HO-1) as an Inhibitor of Trafficking of Normal and Malignant Hematopoietic Stem Cells - Clinical and Translational Implications

NO rapidly mobilizes cellular heme to trigger assembly of its own receptor

Transient regulation of RNA methylation in human hematopoietic stem cells promotes their homing and engraftment

Regulation and Pharmacology of the Cyclic GMP and Nitric Oxide Pathway in Embryonic and Adult Stem Cells

Cd166 Engagement Augments Mouse And Human Hematopoietic Stem And Progenitor Function Via Activation Of Stem Cell-Associated And Cell Cycle Pathways

Mobilization of hematopoietic stem cells as a result of innate immunity-mediated sterile inflammation in the bone marrow microenvironment—the involvement of extracellular nucleotides and purinergic signaling

Structural Basis and Molecular Mechanism of Soluble Guanylate Cyclase in NO-signaling Transduction

Pulse Activation of Retinoic Acid Receptor Enhances Hematopoietic Stem Cell Homing by Controlling CXCR4 Membrane Presentation